Ozempic Cost $935/Month: Is It Worth It? GLP-1 Drugs vs Alternatives for Diabetes

Diabetes Medications · 5 · February 6, 2026

Ozempic costs $935 per month. Mounjaro costs $1,023. That is $11,220 to $12,276 per year. For a drug you may need to take indefinitely.

For that same money, you could get gastric sleeve surgery in India ($4,000–$8,000 at a JCI hospital) with a 50–65% chance of diabetes remission — meaning you might never need medication again. You could buy a year of CGM sensors, a gym membership, and three months of intensive dietary coaching. You could fund a Virta Health ketogenic program ($249/month) for four years.

None of this means GLP-1 drugs are bad. Semaglutide reduces cardiovascular events by 26%. Tirzepatide achieves 62% Type 2 remission in the SURPASS-REMIT trial. These are remarkable drugs. The question is not whether they work — it is whether they are the right first move for every patient.

When GLP-1 Drugs Make Sense

You have Type 2 diabetes and established cardiovascular disease. Semaglutide has proven heart protection — the SUSTAIN and SELECT trials are definitive. If you have had a heart attack or stroke, this drug may save your life.

You have a BMI above 35 and metformin alone is not getting your HbA1c below 7.5%. Tirzepatide's weight loss (14.7% body weight) directly addresses the root cause of insulin resistance.

You have diabetic kidney disease. The FLOW trial showed semaglutide significantly slowed kidney decline.

When Other Options Deserve a Look First

You are newly diagnosed, BMI under 30, HbA1c under 8%. Metformin ($4/month) plus lifestyle changes achieve comparable glucose control for many patients in this profile. The Diabetes Prevention Program showed 58% risk reduction from lifestyle alone.

You are considering long-term medication versus a one-time intervention. Run the numbers on our Metabolic Surgery ROI Calculator. Input your monthly insulin or GLP-1 cost, and see the 10-year comparison. For many patients, surgery is cheaper by year 3.

The Side Effects Nobody Glamourizes

Nausea hits 15–44% of patients. Up to 40% of weight lost is muscle, not fat — a serious concern for anyone over 50. Pancreatitis risk is small but real. Gallbladder disease increases with rapid weight loss. And there is a phenomenon nobody talks about: what happens when you stop. Most patients regain weight and glucose control deteriorates. These are not lifetime cures — they are lifetime commitments at $1,000 per month.

Compare all medication options — including traditional formulations — at our Medication Tracker.